Adrenoleukodystrophy (ALD) is an inherited disorder of fatty acid metabolism marked by accumulation of very long chain saturated fatty acids (VLCFA), especially the 26-carbon acid, hexacosanoic acid (HA), in membranes and tissues. We have studied interactions of 13C-enriched HA with model membranes (phospholipid bilayer vesicles) and bovine serum albumin (BSA) by 13C NMR spectroscopy to compare properties of HA with those of typical dietary fatty acids. In phospholipid bilayers the carboxyl group of HA is localized in the aqueous interface, with an apparent pKa (7.4) similar to other fatty acids; the acyl chain must then penetrate very deeply into the membrane. Desorption of HA from vesicles (t1+2 = 3 h) is orders of magnitude slower than shorter chain fatty acids. In mixtures of vesicles and BSA, HA partitions much more favorably to phospholipid bilayers than typical fatty acids. BSA binds a maximum of only 1 mole of HA at one binding site. Calorimetric experiments show strong perturbations of acyl chains of phospholipids by HA. We predict that disruptive effects of VLCFA on cell membrane structure and function may explain the neurological manifestations of ALD patients. These effects will be further amplified by slow desorption of VLCFA from membranes and by the ineffective binding to serum albumin. 
Introduction
Abnormally high levels of unbranched saturated very long chain fatty acids (VLCFA),' particularly hexacosanoic (C26:0) and 1 . Abbreviations used in this paper: ALD, adrenoleukodystrophy; AMN, adrenomyeloneuropathy; DPPC, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine; DSC, differential scanning calorimetry; HA, hexacosanoic acid; NMR, nuclear magnetic resonance; PC, phosphatidylcholine; VLCFA, very long chain fatty acid. tetracosanoic acid (C24:0) fatty acids, are a characteristic feature of X-linked adrenoleukodystrophy (ALD) (1), a genetically determined disorder associated with progressive destruction of myelin and primary adrenocortical insufficiency. The biochemical and metabolic properties of VLCFA have been extensively studied (2) . The VLCFA excess in ALD is due to the impaired capacity to form their Coenzyme A derivative (3, 4) , a process that normally takes place in the peroxisome (5) . The putative gene defect has been identified recently (6) .
Since the accumulation of VLCFA is the principal and most identifiable biochemical abnormality in ALD, it seems plausible that this change is related to the pathogenesis of the disease. However, at this time there is no proof that this is the case. While correlative data suggest that adrenal insufficiency is a consequence of the accumulation of cholesterol esterified with VLCFA (7), the pathogenesis of the nervous system pathology is not yet understood. Approximately half of the patients succumb in childhood or adolescence to a rapidly progressive destruction of myelin associated with an inflammatory response which involves cytokines (8) and possibly autoimmune mechanisms (9) . The inflammatory response is mild or absent in ALD patients who have a milder phenotype, referred to as adrenomyeloneuropathy (AMN), which manifests in adulthood and is compatible with survival to the seventh or eighth decade. The AMN patients show the same degree of impairment of VLCFA degradation and the same degree of VLCFA accumulation as the boys who succumb in childhood (6, 10) . The VLCFA excess thus is not sufficient as a cause of the rapidly progressive demyelinating process.
Current therapies for ALD include the administration of a mixture of glyceryl trierucate and trioleate oil (also referred to as Lorenzo's Oil), which normalizes the levels of VLCFA in plasma within four weeks (11, 12) . In spite of this promising biochemical effect, clinical results have been disappointing when the oils were fed to symptomatic patients ( 13, 14) . However, a positive result has been obtained in patients in whom therapy was begun before neurological symptoms were present ( 15) , suggesting that the fatty acid abnormality is of pathogenic significance. Up to this time the main support for a direct toxic effect of VLCFA is provided by studies that show that red cell membranes of ALD patients have increased microviscosity and VLCFA content ( 16) and that addition of VLCFA to adrenocortical cells in vitro increases their membrane microviscosity and impairs their capacity to respond to ACTH stimulation (17) .
To investigate further the effect of VLCFA excess on membrane structure and function, we have used biophysical approaches, NMR spectroscopy and differential scanning calorimetry (DSC). 13C NMR spectroscopy has been particularly useful in illuminating properties of fatty acids bound to albumin and to model membranes (18) (19) (20) (21) . Native fatty acids containing a provide spectroscopic information about the local environment of the fatty acid. Moreover, '3C NMR methods can be used to monitor the movement of fatty acid between binding proteins and membranes and determine the partitioning at equilibrium (22, 23) . Previous NMR studies have examined fatty acids ranging in chain length from 8 (octanoic acid) to 18 carbons (oleic and stearic acid) (19-25). DSC provides complementary information about interactions of fatty acids with the acyl chains of phospholipids and has been previously used to study saturated fatty acids with chain lengths of 7-24 carbons (26) (27) (28) .
The present study focuses on a specific VLCFA, the 26 carbon saturated hexacosanoic acid (HA; C26:0), and its interaction with model membranes (phospholipid bilayers) and bovine serum albumin (BSA). HA binds to phospholipid vesicles and exhibits an ionization behavior in the membrane indistinguishable from other fatty acids. However, the acyl chain of HA perturbs the surrounding phospholipids in a manner distinct from other fatty acids. Partitioning to serum albumin from model membranes is not as favorable as its shorter counterparts. In contrast to the multiple binding sites on BSA described previously for fatty acids, only one binding site on albumin is observed for HA. The rate of spontaneous desorption of HA from a phospholipid bilayer transfer is much slower than rates of shorter chain fatty acids. Properties of VLCFA, as elucidated by this study, help explain the pathogenesis of diseases related to these fatty acids. (22, 23) . With this protocol fatty acid is delivered to albumin in a more physiologically relevant manner compared to procedures utilizing organic solvents. Previous studies with fatty acids having chain lengths of [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] carbons found rapid equilibration of fatty acids between phospholipid vesicles and albumin, so that spectra remained unchanged with time (22, 23) . For HA we observed transfer to BSA but found that equilibrium was not reached for several hours, and it was possible to obtain time-dependent spectra showing the kinetics of equilibration. Fig. 2 illustrates spectra at different time intervals for a sample comprised of egg PC vesicles with 2 mol% HA as donor particles and (fatty acid-free) BSA as an acceptor. HA bound to PC vesicles at pH 7.4 ( Fig. 2 A) is represented by the peak at 178.0 ppm, as in Fig. 1 . After addition of BSA, two new weaker signals were seen in the carbonyl region at 181.1 ppm and 182.7 ppm. The peak from HA bound to the vesicles was still relatively intense at the first time point (0-1 h; Fig. 3 B) , but decreased with time (Fig. 3, C ( 19, 32) , it was concluded that this new signal represents HA bound to BSA. The above transfer experiment was carried out with a mass ratio of 2 BSA/PC and a stoichiometric mole ratio of 0.84 HA/ BSA. The same protocol was repeated with equal masses of PC and BSA, the ratio used in analogous studies with other fatty acids (22, 23) , and a stoichiometric ratio of 1.7 HA/BSA. Under these conditions slow transfer (over hours) of HA from PC was also observed, but maximal transfer of HA to BSA was significantly lower (20%, Fig. 3 A) compared to the 2/1 BSA/ PC sample (45%, Fig. 3 B) . The smaller changes in peak intensities precluded quantitative analysis of the transfer kinetics. To investigate further the partitioning as a function of BSA/PC, BSA was added to the 2/1 BSA/PC to make a 3/1 ratio (Fig.  3 C ). An increased partitioning of HA to BSA was observed, but even at this higher BSA/PC some HA was bound to PC vesicles. Note that in Fig. 3 Previous studies have shown that the partitioning of fatty acids (both medium and long-chain) between albumin and PC bilayers is pH-dependent (22, 23) . Because small changes in pH below 7.4 can alter partitioning significantly, we investigated HA partitioning under slightly acidic conditions. Fig. 4 compares spectra (carbonyl region) of a mixture of HA, PC vesicles, and BSA at pH 7.6 and 6.3 after equilibrium partitioning was reached. At pH 7.6 most of the HA was bound to BSA (peak at 182.7 ppm) and the minority to vesicles (smaller peak at 179.1 ppm). When the pH of the solution was decreased to 6.3, the peak representing the binding to BSA (182.7 ppm) diminished greatly in intensity, and a strong signal at 176.5 ppm was observed. The latter peak is at the chemical shift of HA bound to PC vesicles at pH 6.3 in the absence of BSA (Fig.  1) . Thus HA, like other fatty acids (22, 23) acid ( Fig. 5 A) first show the effects of abolishing the pretransition, broadening the main transition, and shifting the midpoint of the main transition to slightly higher temperature. These results indicate that palmitic acid mixes uniformly with the DPPC and has small effects that are transmitted to the bulk of the DPPC molecules. At 10 mole% palmitic acid a second transition at a higher temperature is observed. At higher palmitic acid, this transition grows at the expense of the lower transition and shifts to higher temperature. This new exotherm is explained by phase separation of fatty acid/phospholipid complexes with a higher melting point from pure DPPC. The described behavior of palmitic acid is in essential agreement with previous reports (26) . The DSC results for HA (Fig. 5 B) are significantly different from that of palmitic acid. At 5-7.5 mole% HA the small pretransition shifts to higher temperature and then broadens beyond detection, and the main transition broadens but does not shift. At 10-15 mol% HA, a very broad higher temperature transition, which is complete at 55°C, becomes apparent, and a sharper lower temperature transition centered at 40°C is present. Although the broad transition is not seen at 5 The ionization of the carboxyl group of HA in PC vesicles was not anomalous, showing an apparent pKa of 7.4. Moreover, titration data for HA were nearly identical in all respects (minimum and maximum chemical shifts, linewidths and apparent pKa) with data for fatty acids with chain lengths of [14] [15] [16] [17] [18] carbons (18, 21, 22) . Thus, the molecular environment of the carboxyl group of HA in phospholipid bilayers is indistinguishable from that of shorter chain fatty acids. Specifically, the carboxyl group must be located at the aqueous interface, in an average position similar to that of other fatty acids. With the carboxyl group thus localized, the long acyl must penetrate deeply into the egg PC bilayer comprised primarily of 16-and 18-carbon chains, chain lengths typical of most cell membranes. The DSC results showed that HA has a greater tendency than palmitic acid to induce formation of domains in which the acyl chains of DPPC become more rigidified than the bulk phase. At low concentrations, palmitic acid mixed with DPPC and slightly affected the behavior of the entire DPPC matrix, raising the transition temperature. Palmitic acid at higher concentrations also induced phase separation into higher melting domains, but the domains with HA were even higher melting and therefore more ordered. A destabilizing effect is found for HA but not for palmitic acid, as evidenced by a lower temperature transition, and occurred simultaneously with the stabilizing effect. These seemingly contradictory effects can be explained by the deep penetration of HA into the bilayer. Fig. 6 shows a schematic diagram based on NMR and calorimetric results of how HA might interact with a phospholipid bilayer in a membrane. Since the NMR titration data show that the carboxyl group is localized in the interfacial region, the terminal region of HA will penetrate between the acyl chains of phospholipids on the opposing leaflet or bend in the middle of the bilayer, as illustrated. The DSC results showing a rigidifying effect of HA on neighboring phospholipid acyl chains would most likely be accomplished with the acyl chain lying fairly straight, which would promote ordering of the palmitate chains of the adjacent DPPC molecules all the way to the end of the chain. This conformation would produce a stronger ordering than a typical long chain saturated fatty acid such as palmitic or stearic. The tendency of HA to produce disordering simultaneously with ordering could be explained by the penetration of the same molecule part way into the acyl chains on the opposing leaflet and acting like a small hydrocarbon in this aspect. In the alternative arrangement depicted in Fig. 6 , the presence of a sharp bend in the HA chain to allow the terminal portion to reside in the methyl interior region of the bilayer would likely cause disordering near the ends of all the nearby DPPC chains. The DSC analysis might in this case show only a decrease in the transition temperature reflecting only a disordering effect. Both models of the intercalation of HA into bilayers predict 1460 Ho et al. Number of Carbons in the Acyl Chain Figure 7 . The rate constant for desorption of saturated fatty acids from phospholipid vesicles as a function of chain length. The linear relationship on a semi-log plot of these two variables indicates that the rate of desorption decreases exponentially with increased chain length. The data for myristic, palmitic, and stearic acids (o) are from reference 32, and the data for HA (n) from this study.
another perturbation of bilayer organization, which is the distortion of the phospholipid interface. From steric considerations, the HA is likely to force phospholipid molecules on the opposing leaflet (and possibly the same leaflet) to change their packing in the interface. This effect could alter the binding of proteins and surface antigens and could augment the potential effect of localized ordering caused by HA. The major effect seen by DSC, ordering of phospholipids, is consistent with previous studies showing that VLCFA cause increased microviscosity in cell membranes (16, 17) . As a model system for the transfer of VLCFA between membranes and soluble fatty-acid binding proteins, we studied the more complex aqueous mixture of lipid bilayers, albumin, and HA. This model eliminates energy-dependent and (possibly) protein-mediated uptake of fatty acid and allows focus on physico-chemical partitioning. Our studies with HA yielded several important conclusions: (a) the rate of transfer of HA from phospholipid membranes is much slower than rates for typical dietary fatty acids; (b) the affinity of BSA for HA is lower than that for shorter chain fatty acids; (c) HA resides in a single binding site on albumin, and (d) acidic pH conditions favor the partitioning of HA to membranes, as found for other fatty acids.
From the kinetic analysis of the data for HA desorption from vesicles (Fig. 4) , the half time for HA transfer was found to be 3.2 h. The corresponding observed rate constant kob is 6 X 10-s s -, and the pseudo first order rate constant (k1) calculated from kb. and the partition coefficient (see below) is 3 x 10-5 s-'. The rate constants for transfer of typical dietary fatty acids from phospholipid vesicles to albumin, as determined by fluorescence (32) (Fig. 7) , the fluorescence data fit closely to a straight line on a semi-log plot, and the rate constant for HA is well predicted. The observed first order kinetics suggests that the fatty acids transfer by a solubilized form rather than by collision. It is interesting to note that cholesterol, which has 27 carbons and a single OH, desorbs from PC vesicles with a rate very similar to that of HA (33) .
Although patients where utilization is blocked, and higher levels of VLCFA accumulate, the slow desorption of VLCFA from membranes may augment their deleterious effects for at least two reasons. First, the lifetime in a binding site on the membrane is much longer than lifetimes of shorter chain fatty acids, and effects in a specific environment will be more prolonged. Fatty acids are now known to affect biological activities, such as K+ (35) and Ca"+ (36) channel opening, to act as signals (37) , and to alter intracellular pH (38) . The temporal relationship between fatty acids and membrane proteins may be significantly altered in the case of VLCFA. Secondly, the VLCFA would appear to be a more stable target for enzymatic activation to acyl CoA, and may be more likely to be esterified to lipids or proteins and become an even more long-lived membrane perturbant. In brain white matter HA accumulates primarily in the form of specific esterified lipids. Phosphatidylcholine is 40-fold enriched in HA in ALD patients compared to normals, whereas other glycerophospholipids do not show enrichment in VLCFA (39) . In ALD white matter HA accounted for 3.9-6.2% of total fatty acids in the phosphatidylcholine fraction and between 0.1 and 1.5% in the phosphatidylserine-ethanolamine and inositide fractions compared to 0.1% in all of these fractions in controls. Cholesteryl esters are an extremely minor lipid component in normals but accumulate to high levels in ALD brain white matter and are esterified to a significant extent with VLCFA (40). The fatty acids esterified to myelin proteolipid protein, a double acylated protein which constitutes the major protein of the CNS myelin sheath, also show enrichment in VLCFA (41) .
The`3C NMR spectra of the mixture of vesicles, albumin and HA obtained at equilibrium also show important differences compared to spectra of typical fatty acids. The partitioning of HA to BSA in the presence of membranes is significantly decreased, as shown by comparison with previous data obtained under similar conditions (22, 23) . For example, for an equal weight ratio of BSA and PC at pH 7.4, almost all of the oleic acid is bound to BSA, and the calculated partition coefficient Kp (Methods) is 0.002. For the same BSA/PC ratio in the present study, most of the HA was bound to PC vesicles at pH 7.4 (Fig. 3 A) . The partition coefficient Kp for HA is 0.03, an order of magnitude greater than that of oleic acid, reflecting a much lower affinity of BSA for HA. With a threefold excess of BSA, most of the fatty acid was bound to BSA (Fig. 3 C) , as predicted by the Kp.
The decrease in the relative affinity of BSA for HA compared to membranes may be a result both of a higher affinity of PC vesicles for HA and a lower affinity of BSA for HA in comparison to oleic acid. The latter possibility is suggested by the observation of only one structurally distinct binding site by NMR. Previous equilibrium binding studies suggested decreased binding of VLCFA to albumin [42] ; the maximum '3C NMR Studies of Hexacosanoic Acid 1461 Iy molar ratio obtained with C22:0 was 0.5, compared with up to 10.0 (for laurate, C 12:0). We observed a maximum binding of -1 mole of HA per mole of BSA (Fig. 3 C) (19, 20, 24) , suggesting that the very long chain of HA prevents it from binding in any of the highaffinity sites. We therefore predict that the binding site structure and affinity of serum albumin will promote higher partitioning of HA into membranes, and that albumin will not function to alleviate undesired high concentrations of HA in membranes, as it does with typical fatty acids. The lower affinity of albumin therefore is likely to exacerbate the effects of HA on membrane structure and membrane components.
pH-dependent partitioning. Compared with other fatty acids, HA not only showed similar ionization behavior in phospholipid bilayers (as discussed above), but the partitioning between BSA and PC vesicles was also similarly pH dependent. Slightly lower than physiological pH increased partitioning of HA from BSA to vesicles (Fig. 4) . This finding conforms to previous results with shorter chain fatty acids showing that the uncharged, relative to the charged, form of fatty acid binds more favorably to the phospholipid bilayer (43). The pH-dependent experiments also illustrated the free and reversible movement of HA between vesicles and albumin, a result consistent with the hypothesis of simple physico-chemical partitioning of fatty acids between albumin and membranes (22, 32) . Therefore, we predict that in vivo HA can partition between membranes and serum albumin without mediation by coupling to any energy dependent processes, and with enhanced partitioning to the membrane under acidic pH conditions.
Role of VLCFA excess in the pathogenesis of ALD. The studies presented here indicate that an excess of VLCFA, such as that observed in ALD, can have a profound effect on membrane structure, and that the rate of removal of VLCFA from the membrane may be several orders of magnitude slower than the rates of the more common long chain fatty acids. While our studies were conducted in artificial membrane systems, the observations that membrane microviscosity is increased in red blood cells of ALD patients (16) and that such an increase is associated with impaired ACTH responsiveness in cultured adrenocortical cells (17) suggest that our results are relevant to natural membrane systems.
It thus appears likely that accumulation of VLCFA does have a deleterious effect on membrane structure and function, but it is not yet possible to define the exact role of VLCFA in the pathogenesis of ALD. Correlative studies in postmortem suggested that the adrenocortical insufficiency was caused by the accumulation of cholesterol esterified with VLCFA (7). Ogino et al. (44) have shown that such esters are poor substrates for cholesterol hydrolases, and that this contributes both to their accumulation and to the impaired capacity of the adrenal gland to hydrolyze cholesterol esters in response to ACTH stimulation. (The decreased hydrolysis of cholesteryl esters with VCLFA could be explained by an inability to partition into the interface where hydrolysis occurs [45 ] .) The adrenal pathology of ALD thus may be a consequence both of deleterious effects of VLCFA on membrane structure, and the accumulation of the abnormal cholesterol esters.
The pathogenesis of the nervous system pathology in ALD is complex, and recent studies indicate that it involves at least two mechanisms. Patients with the most severe form of the disease exhibit an acute inflammatory demyelinating process that resembles multiple sclerosis and involves the action of cytokines such as tumor necrosis factor alpha (8) and possibly autoimmune mechanisms (9) . Segregation analysis suggests the action of an autosomal modifier gene (46) which is postulated to modulate the extent of a cytokine or immune-mediated cascade triggered in some way by the VLCFA excess. This "trigger" may be related to a disruption of the membrane structure by VLCFA, or perhaps more likely, VLCFA release may lead to an inflammatory response via cytokine or immune-mediated mechanisms.
As already noted, this inflammatory response is mild or absent in patients with AMN, who survive to adulthood, and in whom the pathology is mainly axonal and involves the distal aspects of the long tracts of the spinal cord (47). Theda et al. (39) have shown that an excess of HA in the phosphatidylcholine fraction appears to be the earliest biochemical abnormality in ALD brain tissue. We speculate that this excess of HA alters nervous system cell membrane function and leads to the progressive axonal dysfunction associated with AMN. Further definition of this postulated pathogenetic mechanism may be aided by in vitro studies of neuronal and glial cultures, although such studies have been hampered so far by the very low solubility of HA.
The implication of the present study that HA may have profound effects on membrane structure suggests that it is warranted to continue efforts to lower HA levels in the nervous system of ALD patients. Recent studies suggest that the limited clinical benefit of "Lorenzo's Oil" is attributable to the failure of erucic acid, the active ingredient of this oil, to enter the nervous system in significant quantity (48, 49) . It is hoped that reduction of brain VLCFA can be achieved by bone marrow transplantation (50) and eventually gene therapy approaches that can be tested in transgenic animal models of ALD now being developed.
